The Animal Depression Medication Market is a rapidly growing industry that caters to the mental health needs of animals. Just like humans, animals can also suffer from depression, anxiety, and other mental health disorders. In recent years, there has been an increase in the awareness of animal mental health, leading to a rise in demand for medication that can treat such conditions.
The global animal depression medication market is expected to reach a valuation of USD 1.5 billion by 2028, growing at a CAGR of 5.8% from 2021 to 2028. The market is primarily driven by the increasing prevalence of depression and anxiety in animals, the rising awareness about animal mental health, and the growing pet population worldwide.